AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 318 filers reported holding AVANOS MED INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,570,893 | -21.6% | 127,146 | -0.9% | 0.00% | 0.0% |
Q2 2023 | $3,279,118 | +61922.3% | 128,291 | -27.8% | 0.00% | -50.0% |
Q1 2023 | $5,287 | -40.8% | 177,771 | -46.2% | 0.00% | -33.3% |
Q4 2022 | $8,937 | -99.9% | 330,264 | -19.1% | 0.00% | -25.0% |
Q3 2022 | $8,888,000 | -45.5% | 408,078 | -31.5% | 0.00% | -33.3% |
Q2 2022 | $16,299,000 | -14.9% | 596,135 | +0.1% | 0.01% | 0.0% |
Q1 2022 | $19,144,000 | -10.4% | 595,251 | -3.4% | 0.01% | 0.0% |
Q4 2021 | $21,365,000 | +29.6% | 616,248 | +16.7% | 0.01% | +20.0% |
Q3 2021 | $16,482,000 | -16.7% | 528,255 | -2.9% | 0.01% | -16.7% |
Q2 2021 | $19,784,000 | +56.2% | 543,968 | +87.8% | 0.01% | +50.0% |
Q1 2021 | $12,667,000 | +19.9% | 289,614 | +25.7% | 0.00% | 0.0% |
Q4 2020 | $10,568,000 | +40.1% | 230,351 | +1.4% | 0.00% | +33.3% |
Q3 2020 | $7,545,000 | +20.1% | 227,131 | +6.2% | 0.00% | 0.0% |
Q2 2020 | $6,284,000 | +15.7% | 213,809 | +6.0% | 0.00% | 0.0% |
Q1 2020 | $5,430,000 | -19.7% | 201,622 | +0.5% | 0.00% | 0.0% |
Q4 2019 | $6,762,000 | -10.0% | 200,665 | +0.1% | 0.00% | 0.0% |
Q3 2019 | $7,513,000 | -13.8% | 200,557 | +0.3% | 0.00% | 0.0% |
Q2 2019 | $8,718,000 | – | 199,897 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |